What is King Pharmaceuticals's general liability — total IBNR?

King Pharmaceuticals (KG) reported general liability — total IBNR of 4,098,200,000% in Q4 2025.

What does general liability — total IBNR mean?

This represents the total estimated liability for claims that have been incurred but not yet reported to the insurer. It is a critical actuarial reserve component that accounts for the uncertainty and time lag inherent in general liability claim reporting.

King Pharmaceuticals KG General Liability — Total IBNR

Other product segments

European Hospital Liability

1,391,000,000%—

Commercial Auto Liability

715,500,000%—

All other lines

551,000,000%—

International

313,500,000%—

Similar metrics at other companies

CNAGeneral Liability — IBNR

341,000,000,000%+19,500,000,000pp

SIGIGeneral liability — IBNR

$769.16M+23.9%

HIGGeneral Liability — IBNR Reserves

$1.63B+19.0%

TRVGeneral Liability — IBNR Reserves Dec. 31, 2025 (Audited)

313,100,000,000%+29,500,000,000pp

KMPRSpecialty Personal Automobile Insurance—Liability — Total of IBNR Liabilities Plus Expected Development on Reported Claims

$630.3M+24.6%

CNAOther Professional Liability and Management Liability — IBNR

268,900,000,000%+100,000,000pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's general liability — total ibnr.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's general liability — total IBNR?: King Pharmaceuticals (KG) reported general liability — total IBNR of 4,098,200,000% in Q4 2025.
What does general liability — total IBNR mean?: This represents the total estimated liability for claims that have been incurred but not yet reported to the insurer. It is a critical actuarial reserve component that accounts for the uncertainty and time lag inherent in general liability claim reporting.